Clinical Neurophysiology Research Laboratory, Western Psychiatric Hospital, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Clinical Neurophysiology Research Laboratory, Western Psychiatric Hospital, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Psychiatry Res. 2024 Sep;339:116094. doi: 10.1016/j.psychres.2024.116094. Epub 2024 Jul 21.
Predicting treatment response would facilitate individualized medical treatment in first-episode psychosis (FEP). We examined relationships between auditory-evoked M100 and longitudinal change in positive symptoms in FEP. M100 was measured from source-resolved magnetoencephalography and symptoms were assessed at initial contact and six months later. M100 at baseline significantly predicted symptom change. Larger M100 at baseline predicted symptom improvement, as did shorter untreated psychosis. Shorter untreated psychosis also correlated with larger M100, and M100 mediated the effect of untreated psychosis on treatment response. Thus, M100 may provide a proximal and objective index of untreated psychosis and a viable route to individualized medicine.
预测治疗反应将有助于在首发精神病(FEP)中进行个体化医疗。我们研究了 FEP 中听觉诱发电位 M100 与阳性症状的纵向变化之间的关系。M100 是从源分辨脑磁图测量的,症状在初次接触和六个月后进行评估。基线时的 M100 显著预测症状变化。较大的基线 M100 预示着症状改善,未治疗的精神病时间较短也是如此。未治疗的精神病时间较短也与较大的 M100 相关,并且 M100 介导了未治疗的精神病对治疗反应的影响。因此,M100 可能提供未治疗的精神病的近侧和客观指标,以及个体化医学的可行途径。